Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia.
作者信息
Arango Celso, Kapur Shitij, Kahn René S
机构信息
Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM, Madrid, Spain;
Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK;
出版信息
Schizophr Bull. 2015 May;41(3):546-8. doi: 10.1093/schbul/sbv026.
Abstract
摘要
相似文献
1
Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia.超越精神科治疗中的“反复试验”：优化首发精神分裂症的治疗
Schizophr Bull. 2015 May;41(3):546-8. doi: 10.1093/schbul/sbv026.
2
DSM-5 dimensions of Schizophrenia enable measurement-based care to individualize pharmacological treatment.《精神疾病诊断与统计手册》第五版中精神分裂症的维度使基于测量的护理能够实现药物治疗的个体化。
Asian J Psychiatr. 2016 Dec;24:A1-A2. doi: 10.1016/j.ajp.2016.11.009.
3
[The Cochrane collaboration].[考克兰协作网]
Aten Primaria. 1996 Oct 15;18(6):273-6, 278.
4
Evaluating clinical trial data: outcome measures.评估临床试验数据：结局指标
J Clin Psychiatry. 2001;62 Suppl 9:23-6; discussion 27-8.
5
Clinical effectiveness in first-episode patients.首发患者的临床疗效。
Eur Neuropsychopharmacol. 2004 Nov;14 Suppl 4:S445-51. doi: 10.1016/j.euroneuro.2004.08.003.
6
Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST).抗精神病药物对首发精神分裂症自知力的不同影响：来自欧洲首发精神分裂症试验（EUFEST）的数据。
Eur Neuropsychopharmacol. 2015 Jun;25(6):808-16. doi: 10.1016/j.euroneuro.2015.02.012. Epub 2015 Apr 20.
7
Patients with a first episode of schizophrenia spectrum psychosis and their pathways to psychiatric hospital care in South Germany.德国南部首次发作精神分裂症谱系精神病患者及其前往精神病院就医的途径。
Soc Psychiatry Psychiatr Epidemiol. 2004 May;39(5):375-80. doi: 10.1007/s00127-004-0767-z.
8
The staging model in schizophrenia, and its clinical implications.精神分裂症的分期模型及其临床意义。
Psychiatr Danub. 2010 Jun;22(2):211-20.
9
Deinstitutionalization revisited: a 5-year follow-up of a randomized clinical trial of hospital-based rehabilitation versus specialized assertive intervention (OPUS) versus standard treatment for patients with first-episode schizophrenia spectrum disorders.再探去机构化：一项针对首发精神分裂谱系障碍患者的基于医院的康复治疗与专项积极干预（OPUS）对比标准治疗的随机临床试验的 5 年随访。
Psychol Med. 2010 Oct;40(10):1619-26. doi: 10.1017/S0033291709992182. Epub 2010 Jan 11.
10
Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST.首发精神分裂症治疗中的锥体外系症状：EUFEST 研究结果。
Eur Neuropsychopharmacol. 2014 Sep;24(9):1500-5. doi: 10.1016/j.euroneuro.2014.07.001. Epub 2014 Jul 21.
引用本文的文献
1
Functional Connectivity Biomarkers in Schizophrenia.精神分裂症的功能连接生物标志物。
Adv Neurobiol. 2024;40:237-283. doi: 10.1007/978-3-031-69491-2_10.
2
Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers.精神病的生物标志物：我们做到了吗？对1478种生物标志物的综合评价
Schizophr Bull Open. 2024 Aug 30;5(1):sgae018. doi: 10.1093/schizbullopen/sgae018. eCollection 2024 Jan.
3
Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with Schizophrenia.美国医疗保险受益的精神分裂症患者全国样本中口服抗精神病药物的真实世界依从性、停药情况及相关因素
Clinicoecon Outcomes Res. 2024 Aug 14;16:567-579. doi: 10.2147/CEOR.S469001. eCollection 2024.
4
Appraisal of patient-level health economic models of severe mental illness: systematic review.严重精神疾病患者层面健康经济模型评估：系统评价
Br J Psychiatry. 2021 Aug 19;220(2):1-12. doi: 10.1192/bjp.2021.121.
5
Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders.精神分裂症谱系障碍和双相情感障碍治疗第一年抗精神病药物剂量变化的预测因素
Front Psychiatry. 2019 Sep 10;10:649. doi: 10.3389/fpsyt.2019.00649. eCollection 2019.
6
First-Episode Psychosis Research: Time to Move Forward (by Looking Backwards).首发精神病研究：回顾过去以迈向未来。
Schizophr Bull. 2015 Nov;41(6):1205-6. doi: 10.1093/schbul/sbv126. Epub 2015 Sep 20.
本文引用的文献
1
Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research.磁共振成像与首发精神分裂症的预后预测：当前证据综述及未来研究方向
Schizophr Bull. 2015 May;41(3):574-83. doi: 10.1093/schbul/sbv024. Epub 2015 Mar 23.
2
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.欧洲精神分裂症治疗与管理优化（OPTiMiSE）试验：其方法原理及抗精神病药物换药有效性综述
Schizophr Bull. 2015 May;41(3):549-58. doi: 10.1093/schbul/sbv019. Epub 2015 Mar 18.
3
The promise of biological markers for treatment response in first-episode psychosis: a systematic review.首发精神病治疗反应生物标志物的前景：一项系统综述
Schizophr Bull. 2015 May;41(3):559-73. doi: 10.1093/schbul/sbv002. Epub 2015 Mar 10.
4
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.抗精神病药物在首发精神分裂症和分裂样障碍中的疗效：一项开放性随机临床试验。
Lancet. 2008 Mar 29;371(9618):1085-97. doi: 10.1016/S0140-6736(08)60486-9.
Zotero 插件